NEUROBIOLOGY OF AGING
Scope & Guideline
Bridging Research and Innovation in Aging Neuroscience
Introduction
Aims and Scopes
- Neurodegenerative Disease Mechanisms:
Research on the biological and neurological underpinnings of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s disease, including genetic, molecular, and cellular mechanisms. - Cognitive Aging:
Exploration of the cognitive decline associated with aging, including studies on memory, attention, and executive function across different age groups. - Neuroimaging and Biomarkers:
Utilization of advanced neuroimaging techniques and biomarkers to study brain structure and function in aging populations, focusing on identifying early signs of neurodegeneration. - Role of Lifestyle Factors:
Investigating how lifestyle choices, such as physical activity, diet, and cognitive engagement, influence brain health and cognitive resilience in aging. - Neuroinflammation and Aging:
Study of the role of neuroinflammation in the aging brain and its contribution to cognitive decline and neurodegenerative processes. - Sex and Gender Differences:
Examination of how biological sex and gender differences influence aging processes, neurodegeneration, and cognitive outcomes.
Trending and Emerging
- Multimodal Approaches:
An increasing number of studies are utilizing multimodal research designs, combining neuroimaging, genetic analysis, and cognitive assessments to provide a comprehensive understanding of aging. - Precision Medicine and Genetics:
There is a growing emphasis on genetic risk factors and personalized medicine approaches in understanding Alzheimer's disease and other neurodegenerative conditions. - Impact of Lifestyle on Brain Health:
Research is increasingly focusing on how lifestyle factors, such as diet, exercise, and cognitive engagement, can mitigate cognitive decline and promote brain health. - Neuroinflammation as a Therapeutic Target:
The role of neuroinflammation in aging and neurodegeneration is gaining traction, with studies exploring potential therapeutic interventions to modulate inflammatory processes. - Cognitive Reserve and Resilience:
Emerging interest in cognitive reserve and resilience mechanisms, examining how individuals can maintain cognitive function despite neurobiological changes associated with aging.
Declining or Waning
- Animal Models of Aging:
There appears to be a decline in the number of studies focusing on aging in specific animal models, such as rodents, as researchers increasingly prioritize human studies and translational research. - Pharmacological Interventions:
Research centered on pharmacological treatments for cognitive decline and neurodegenerative diseases has decreased, possibly due to a shift towards lifestyle and non-pharmacological interventions. - Epidemiological Studies:
There is a waning emphasis on large-scale epidemiological studies in favor of more mechanistic and experimental approaches that delve deeper into specific biological processes.
Similar Journals
American Journal of Alzheimers Disease and Other Dementias
Exploring the frontiers of dementia research.The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.
BRAIN RESEARCH
Exploring the intricate connections of neural systems.BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.
ARCHIVES OF GERONTOLOGY AND GERIATRICS
Shaping the future of geriatric practice through research.The Archives of Gerontology and Geriatrics, published by Elsevier Ireland Ltd, is a leading journal in the fields of Aging and Geriatrics and Gerontology. With an ISSN of 0167-4943 and an E-ISSN of 1872-6976, it has established itself as a crucial platform for disseminating high-quality research focused on the biological and psychosocial aspects of aging. The journal holds an impressive Q2 ranking in both Aging and Geriatrics and Gerontology, and a Q1 ranking in Gerontology and Health (Social Science) as of 2023, reflecting its significant impact in these disciplines. Additionally, the journal is ranked #33/371 in Social Sciences (Health) and #5/39 in Nursing (Gerontology) according to Scopus, showcasing its esteemed position in the academic community. Although currently not open access, the journal offers a wealth of research articles from 1982 to the upcoming 2025 that are vital for stakeholders including researchers, healthcare professionals, and students aiming to advance their understanding of aging processes and policies. Titles published within its pages contribute to shaping agendas in public health and gerontological practice, making it an essential resource for those involved in the study of the elderly population.
NATURE NEUROSCIENCE
Pioneering New Paths in Understanding the BrainNATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.
EXPERIMENTAL AGING RESEARCH
Innovating Knowledge for a Longer LifeEXPERIMENTAL AGING RESEARCH, published by Taylor & Francis Inc., is a leading journal that has been at the forefront of aging research since its inception in 1975. With an ISSN of 0361-073X and an E-ISSN of 1096-4657, this journal has earned a notable reputation, including a Q3 ranking in the field of Aging and impressive Q1 and Q2 rankings in Arts and Humanities and Geriatrics and Gerontology respectively. This positions the journal within the top percentile of its category, highlighting its significant impact and contribution to the scientific community. Covering a broad scope that intersects various disciplines, EXPERIMENTAL AGING RESEARCH aims to disseminate pioneering research, foster interdisciplinary collaboration, and provide a platform for innovative studies that enhance understanding of the aging process. While it currently does not offer Open Access, researchers and academics can access its rich repository of knowledge that spans multiple facets of aging, from physiological changes to psychological impacts. As the field of aging continues to evolve, this journal remains an essential resource for researchers, professionals, and students dedicated to advancing knowledge and practices concerning aging and longevity.
BIOGERONTOLOGY
Bridging Disciplines to Enhance Our Knowledge of AgingBIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.
EXPERIMENTAL GERONTOLOGY
Advancing the Science of Aging for a Healthier TomorrowEXPERIMENTAL GERONTOLOGY is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the evolving field of aging research. With a rich history dating back to 1964 and continuing through 2024, this journal aims to advance the understanding of the biological processes underlying aging and develop interdisciplinary approaches to improve healthspan. ENCOMPASSING a broad scope, including *biochemistry*, *cell biology*, *endocrinology*, *genetics*, and *molecular biology*, it holds impressive rankings in the 2023 Scopus Ranks, featuring in Q1 and Q2 quartiles across multiple categories. This positions it as a vital resource for researchers and professionals focused on gerontology and related fields. As a subscription-based journal without open access, EXPERIMENTAL GERONTOLOGY ensures the dissemination of high-quality research through rigorous peer review, making it an essential publication for those aspiring to remain at the forefront of aging studies.
Clinical Interventions in Aging
Shaping the Future of Geriatrics and GerontologyClinical Interventions in Aging is a premier Open Access journal published by DOVE MEDICAL PRESS LTD that has been at the forefront of geriatric research since its inception in 2006. With its core focus on innovative interventions and evidence-based practices to enhance the quality of life for the elderly, this journal serves as a vital resource for researchers, healthcare professionals, and students in the fields of geriatrics and gerontology. The journal boasts a commendable impact factor, achieving a Q2 ranking in Geriatrics and Gerontology and a Q1 ranking in Medicine (miscellaneous) as of 2023, highlighting its significant academic contribution. Notably, its Scopus ranking places it in the top 31% of its category, underscoring the relevance and quality of the research it publishes. With a commitment to advancing knowledge, this journal not only promotes accessibility through its Open Access model but also ensures that cutting-edge studies are readily available to those dedicated to improving geriatric care. Located in Auckland, New Zealand, the journal continues to expand its influence globally, making it an essential platform for discussions surrounding aging and health.
Aging Brain
Fostering Innovation in Gerontology and NeuroscienceAging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.
npj Aging
Unlocking the secrets of biological and social aging.npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.